Alzheimer's Disease (AD) is the main neurodegenerative disease worldwide affecting more than 15 Mill. people. An easy AD blood diagnostic method does not exist, as well as an early predictive AD biomarker. Scientists of the University of Göttingen identified a novel Blood Biomarker for the Diagnosis of Alzheimer's Disease (AD) which correlates with the cognitive status of individuals at risk to develop AD including mild cognitive impairment (MCI) patients, as well as a corresponding ELISA methodology.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
